- Home
- SIGA vs CURI Comparison
SIGA vs CURI Comparison
Compare SIGA & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- CURI
- Stock Information
- Founded
- SIGA 1995
- CURI N/A
- Country
- SIGA United States
- CURI United States
- Employees
- SIGA N/A
- CURI N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- CURI Movies/Entertainment
- Sector
- SIGA Health Care
- CURI Consumer Discretionary
- Exchange
- SIGA Nasdaq
- CURI Nasdaq
- Market Cap
- SIGA 422.9M
- CURI 394.5M
- IPO Year
- SIGA 1997
- CURI N/A
- Fundamental
- Price
- SIGA $6.77
- CURI $4.49
- Analyst Decision
- SIGA
- CURI Strong Buy
- Analyst Count
- SIGA 0
- CURI 2
- Target Price
- SIGA N/A
- CURI $5.40
- AVG Volume (30 Days)
- SIGA 382.0K
- CURI 833.1K
- Earning Date
- SIGA 07-31-2025
- CURI 08-12-2025
- Dividend Yield
- SIGA 8.70%
- CURI 7.14%
- EPS Growth
- SIGA N/A
- CURI N/A
- EPS
- SIGA 0.67
- CURI N/A
- Revenue
- SIGA $120,330,310.00
- CURI $54,223,000.00
- Revenue This Year
- SIGA N/A
- CURI $24.74
- Revenue Next Year
- SIGA $95.31
- CURI $13.30
- P/E Ratio
- SIGA $10.28
- CURI N/A
- Revenue Growth
- SIGA N/A
- CURI N/A
- 52 Week Low
- SIGA $4.95
- CURI $0.99
- 52 Week High
- SIGA $12.83
- CURI $7.15
- Technical
- Relative Strength Index (RSI)
- SIGA 61.28
- CURI 38.56
- Support Level
- SIGA $6.34
- CURI $4.55
- Resistance Level
- SIGA $7.07
- CURI $4.68
- Average True Range (ATR)
- SIGA 0.22
- CURI 0.32
- MACD
- SIGA 0.02
- CURI -0.09
- Stochastic Oscillator
- SIGA 71.70
- CURI 3.72
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.